Inventiva (IVA) said late Wednesday it appointed Jason Campagna as chief medical officer and president of research and development.
Campagna succeeds Michael Cooreman, who is departing as chief medical officer. Co-founder and Chief Scientific Officer Pierre Broqua will transition to a consulting role as scientific advisor.
Campagna most recently was the chief medical officer at Q32 Bio (QTTB), Inventiva said.